European Journal of General Practice
Volume 26, 2020 - Issue 1
Original Article
Adverse events of targeted therapies reported by patients with cancer treated in primary care
Samuel RogerDepartment of General Practice, University Rennes, Rennes, France;CHU Rennes, INSERM, CIC 1414 (Centre d’investigation clinique de Rennes), University Rennes, Rennes, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-8647-8931
https://orcid.org/0000-0002-8647-8931, Julien EdelineDepartment of Medical Oncology, Centre Eugène Marquis, Rennes, Francehttps://orcid.org/0000-0002-8289-7741
https://orcid.org/0000-0002-8289-7741, Boris Campillo-GimenezINSERM, LTSI U1099, Rennes, France;Clinical Research Department, Centre Eugene Marquis, Rennes, Francehttps://orcid.org/0000-0002-2329-5265
https://orcid.org/0000-0002-2329-5265, , Marie-Eve Rouge-BugatDepartment of General Practice, University Toulouse, Toulouse, Francehttps://orcid.org/0000-0002-3562-5815
https://orcid.org/0000-0002-3562-5815 & Anthony ChapronDepartment of General Practice, University Rennes, Rennes, France;CHU Rennes, INSERM, CIC 1414 (Centre d’investigation clinique de Rennes), University Rennes, Rennes, Francehttps://orcid.org/0000-0002-4997-8486
https://orcid.org/0000-0002-4997-8486